Search Results For ''

  • ResApp expands their diagnostic offering into disease affecting 1 billion worldwide

    Experts estimate that sleep apnoea affects nearly 1 billion people worldwide. Every year, 4 million people die prematurely from chronic respiratory diseases such as COPD, asthma, acute respiratory tract infections, tuberculosis and lung cancer.  The global impact of respiratory based ailments is expansive, prompting The World Health Organisation to launch the Global Alliance Against Respiratory

    Read More
    Public
  • Markets set for a muted start to the week

    US markets on Friday closed slightly lower but finished to week higher. We have likely seen the worst of the selling for now as the US has kicked the debt ceiling issues out to December. Investors will likely wait for the reporting to kick off before buying too much more into this market. Fastenal will

    Read More
    Public
  • Rewardle foregoes fees in preference of equity stake in BNPL SplitPay

    Give a man a fish, he eats for a day. Teach a man to fish he eats for a lifetime.  This is the mantra being undertaken by marketing tech company Rewardle (ASX: RXH) which is passing on up to $60k worth of fees for a 1% equity stake in buy-now-pay-later operator SplitPay.  At that ratio,

    Read More
    Public
  • US kicks the can out to December

    US markets recovered somewhat overnight after a compromise to extend the debt ceiling to fund operations through to early December. This gives the Democrats some time to come to a longer-term solution to fund the government and bides 3.5 trillion spending agenda. The major US indices did not hold the high for the day, giving

    Read More
    Public
  • Preparing for a banking licence, Novatti increases its stake in proposed neobank

    There is an air of confidence around digital payments company Novatti Group (ASX: NOV) which has increased its equity stake in their neobank subsidiary, giving the Aussie fintech a 70% stake in the business expected to be granted its banking license soon. Already a global financial institution, banking services have been on the agenda for

    Read More
    Public
  • Contraceptive alternatives – Mayne Pharma receives FDA response putting them a step closer to approval

    Of the myriad of contraceptives out there, those that don’t require daily effort are gaining in popularity. As our lives get busier and brains get fuller, women are electing for long term, ‘set and forget’ birth control measures. Two thirds of Australian women of reproductive age use birth control. Whilst methods like the oral contraceptive

    Read More
    Public